Cargando…

A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †

The current study aims to evaluate whether prophylactic anticoagulation using argatroban or an increased dose of unfractionated heparin (UFH) is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant (HR) patients. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bachler, Mirjam, Hell, Tobias, Bösch, Johannes, Treml, Benedikt, Schenk, Bettina, Treichl, Benjamin, Friesenecker, Barbara, Lorenz, Ingo, Stengg, Daniel, Hruby, Stefan, Wallner, Bernd, Oswald, Elgar, Ströhle, Mathias, Niederwanger, Christian, Irsara, Christian, Fries, Dietmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230377/ https://www.ncbi.nlm.nih.gov/pubmed/32244368 http://dx.doi.org/10.3390/jcm9040963

Ejemplares similares

Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019)

Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study
por: Ziegler, Bernhard, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Tigecycline Interferes with Fibrinogen Polymerization Independent of Peripheral Interactions with the Coagulation System
por: Brandtner, Anna, et al.
Publicado: (2020)

Antithrombin deficiency is associated with mortality and impaired organ function in septic pediatric patients: a retrospective study
por: Niederwanger, Christian, et al.
Publicado: (2018)

Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis
por: Treml, Benedikt, et al.
Publicado: (2021)

First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion—Further Results of the RETIC Study
por: Innerhofer, Nicole, et al.
Publicado: (2021)

Response patterns of routinely measured inflammatory and coagulatory parameters in sepsis
por: Bachler, Mirjam, et al.
Publicado: (2019)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Difficult reversal of dabigatran with idarucizumab in a multiple-trauma patient: A question of dose?
por: Ströhle, Mathias, et al.
Publicado: (2021)

Red Bull Increases Heart Rate at Near Sea Level and Pulmonary Shunt Fraction at High Altitude in a Porcine Model
por: Treml, Benedikt, et al.
Publicado: (2020)

Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion—A Sub-Study of the Randomized Controlled RETIC Trial
por: Tauber, Helmuth, et al.
Publicado: (2020)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Comparison of pediatric scoring systems for mortality in septic patients and the impact of missing information on their predictive power: a retrospective analysis
por: Niederwanger, Christian, et al.
Publicado: (2020)

Impaired fibrinolysis in critically ill COVID-19 patients
por: Bachler, Mirjam, et al.
Publicado: (2021)

Inflammatory and coagulatory parameters linked to survival in critically ill children with sepsis
por: Niederwanger, Christian, et al.
Publicado: (2018)

ICU-Acquired Hypernatremia Is Associated with Persistent Inflammation, Immunosuppression and Catabolism Syndrome
por: Rugg, Christopher, et al.
Publicado: (2020)

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
por: Bredthauer, Andre, et al.
Publicado: (2020)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis
por: Yokota, Yuya, et al.
Publicado: (2019)

Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis
por: Rugg, Christopher, et al.
Publicado: (2020)

Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
por: Marchetti, Matteo, et al.
Publicado: (2022)

Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
por: Schenk, Bettina, et al.
Publicado: (2018)

FITC-linked Fibrin-Binding Peptide and real-time live confocal microscopy as a novel tool to visualize fibrin(ogen) in coagulation
por: Weiss, Nikolaj, et al.
Publicado: (2017)

Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting
por: Klingele, Matthias, et al.
Publicado: (2020)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Necrotizing fasciitis of the lower extremity caused by perforated sigmoid diverticulitis—a case report
por: Kröpfl, Veronika, et al.
Publicado: (2018)

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2010)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
por: Nakagawa, Tetsuya
Publicado: (2008)

Fibrinogen (FI)
por: Fries, Dietmar, et al.
Publicado: (2015)

The Influence of Environmental Hypoxia on Hemostasis—A Systematic Review
por: Treml, Benedikt, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kboqp120gf19pok239o7e98k5u